Moneycontrol PRO
HomeNewsTrendsHealth aggregators may join COVID-19 vaccination drive: Report

Health aggregators may join COVID-19 vaccination drive: Report

Companies like Medibuddy, Pharmeasy and 1mg are in talks with manufacturers to gain supplies of vaccines that they will provide to apartment complexes, neighbourhood clinics and dispensaries and small towns.

April 23, 2021 / 13:14 IST
A health worker checks the Covishied, a COVID-19 vaccine manufactured by Serum Institute of India, as she prepares to start vaccination against COVID-19. (Representative image: Reuters)

Health aggregators are expected to join India’s expanded vaccination drive which from May 1 will include everyone over the age of 18.

Players such as Medibuddy, Pharmeasy and 1mg are in talks with vaccine manufacturers to gain supplies of vaccines, which they will provide to apartment complexes, neighbourhood clinics and dispensaries, office campuses and small towns, The Economic Times has reported .

Moneycontrol could not independently verify the report.

Follow our LIVE Updates on the coronavirus pandemic here

India is in the middle of a ferocious second wave, with daily reported infection topping 3 lakh for the second consecutive day on April 23.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

While expanding the vaccination drive, the Centre has also allowed states to acquire 50 percent of their vaccine requirement and allowed private parties to vaccinate individuals.

The players are also in talks with the Centre-run CoWin platform to integrate systems and ensure that all vaccinations are counted, industry sources told the paper.

If these companies are “onboarded” into the country’s vaccination drive, they’ll bring with them resources in form of a huge network of doctors, clinics and healthcare workers beyond the current 7,000 government and 7,000 private centres offering vaccinations at present.

Prashant Tandon, founder of 1mg, said, “Vaccination needs to be a neighbourhood activity and since major hospitals are overburdened, network providers like us have a huge role to play.” He further said that customers can use their portal to book their vaccine appointment.

The company is also in talks with corporates and housing societies to set up vaccination camps.

Check here for the latest updates on all COVID-19 vaccines

A government official told the paper that these companies are also asking the Centre to “open up integration of CoWin platform with their systems”.

Meena Ganesh, MD & CEO of Portea Medical, a home healthcare provider,  said they have set up a cold chain across 30 cities and have trained manpower to administer the vaccine. “The idea is to procure directly and set up camps in large corporates, factories and housing complexes,” she added.

Pharmeasy CEO Dharmil Sheth said, “More than million customers have locked in demand for vaccines with us. It is larger groups as well as corporates. We will be able to provide over 5 million customers in the next couple of months.”

The company plans to conduct vaccination camps, supply vaccines to nursing homes and doctors (first in 12 and later 25-30 cities) and connect customers with vaccination centres.

MediBuddy CEO Satish Kannan said its customers were demanding vaccines. He felt said vaccine shortage and supply may be an issue but note prices as market would take care of overpricing.

Follow our full COVID-19 coverage here

Moneycontrol News
first published: Apr 23, 2021 01:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347